logo
logo

Eye Drug Maker Neurophth Snags $63M Series C Co-Led By Sequoia China

Eye Drug Maker Neurophth Snags $63M Series C Co-Led By Sequoia China

11/29/21, 5:50 AM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/CN.svgchina
Money raised
$63 million
Round Type
series c
Ophthalmic diseases-driven therapy specialist Neurophth Biotechnology has raised nearly 400 million yuan ($63 million) in a Series C round of financing, per a company statement on Monday

Company Info

Company
Neurophth
Location
china
Additional Info
The company has developed a pipeline of 10 products. The company received approval from the National Medical Products Administration in June this year.